medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 6

Siguiente >>

Rev Invest Clin 2016; 68 (6)


Obstructive Sleep Apnea and Perinatal Risk

Reyes-Zúñiga M, Torre-Bouscoulet L

Idioma: Ingles.
Referencias bibliográficas: 37
Paginas: 281-285
Archivo PDF: 66.67 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Carrillo-Alduenda JL, Arredondo-del-Bosque F, Reyes-Zúñiga M, Castorena-Maldonado A, Vázquez-García JC, Torre-Bouscoulet L. [Obstructive sleep apnea syndrome in adult population.] Neumol Cir Torax. 2010;69:103-15.

  2. Torre-Bouscoulet L, Castorena-Maldonado A, Sada-Ovalle I, Meza- Vargas MS. [Mechanisms of cardiovascular damage in obstructive sleep apnea]. Rev Invest Clin. 2008;60:502-16.

  3. Young T, Palta M, Dempsey J, et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5.

  4. Bouscoulet LT, Vázquez-García JC, Muiño A, et al. Prevalence of sleep-related symptoms in 4 Latin American cities. J Clin Sleep Med. 2008;4:579-85.

  5. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006-14.

  6. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-53.

  7. Garbarino S, Guglielmi O, Sanna A, Mancardi GL, Magnavita N. Risk of occupational accidents in workers with obstructive sleep apnea: Systematic review and meta-analysis. Sleep. 2016;39:1211-8.

  8. Karimi M, Hedner J, Häbel H, Nerman O, Grote L. Sleep apnearelated risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data. Sleep. 2015;38:341-9.

  9. Garvey JF, Pengo MF, Drakatos P, Kent BD. Epidemiological aspects of obstructive sleep apnea. J Thorac Dis. 2015;7:920-9.

  10. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleepdisordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2012; 186:190-4.

  11. Louis JM, Mogos MF, Salemi JL, Redline S, Salihu HM. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep. 2014;37:843-9.

  12. Pamidi S, Pinto LM, Marc I, Benedetti A, Schwartzman K, Kimoff RJ. Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and meta analysis. Am J Obstet Gynecol. 2014;210:52.e1-14.

  13. Ding XX, Wu YL, Xu SJ, et al. A systematic review and quantitative assessment of sleep-disordered breathing during pregnancy and perinatal outcomes. Sleep Breath. 2014;18:703-13.

  14. Louis J, Auckley D, Miladinovic B, et al. Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol. 2012;120:1085-92.

  15. Pien GW, Pack AI, Jackson N, Maislin G, Macones GA, Schwab RJ. Risk factors for sleep-disordered breathing in pregnancy. Thorax. 2014;69:371-7.

  16. Wilson DL, Walker SP, Fung AM, O’Donoghue F, Barnes M, Howard M. Can we predict sleep-disordered breathing in pregnancy? The clinical utility of symptoms. J Sleep Res. 2013;22:670-8.

  17. Antony KM, Agrawal A, Arndt ME, et al. Association of adverse perinatal outcomes with screening measures of obstructive sleep apnea. J Perinatol. 2014;34:441-8.

  18. Bourjeily G, Barbara N, Larson L, He M. Clinical manifestations of obstructive sleep apnoea in pregnancy: more than snoring and witnessed apnoeas. J Obstet Gynaecol. 2012;32:434-8.

  19. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados nacionales. 2a. ed. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2013.

  20. World Health Organisation. Millennium objectives. Available at: http://www.who.int/topics/millennium_development_goals/ about/es/

  21. Pamidi S, Marc I, Simoneau G, Lavigne L, Olha A, Benedetti A, et al. Maternal sleep-disordered breathing and the risk of delivering small for gestational age infants: a prospective cohort study. Thorax. 2016;71:719-25.

  22. McIntire DD1, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med. 1999;340:1234-8.

  23. Tapia IE, Shults J, Doyle LW, et al. Perinatal risk factors associated with the obstructive sleep apnea syndrome in school-aged children born preterm. Sleep. 2016;39:737-42.

  24. Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr. 2003;142: 383-9.

  25. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med. 2005;172:1363-70.

  26. Cooper VL, Pearson SB, Bowker CM, Elliott MW, Hainsworth R. Interaction of chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension in obstructive sleep apnoea. J Physiol. 2005;568:677-87.

  27. Schöbel C, Fietze I, Glos M, et al. Nocturnal snoring decreases daytime baroreceptor sensitivity. Respir Med. 2014;108:1049-55.

  28. Muñoz-Hernandez R, Vallejo-Vaz AJ, Sanchez Armengol A, et al. Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP. PLoS One. 2015;10:e0122091.

  29. Varadharaj S, Porter K, Pleister A, et al. Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction. Respir Physiol Neurobiol. 2015;207: 40-7.

  30. Korcarz CE, Stein JH, Peppard PE, Young TB, Barnet JH, Nieto FJ. Combined effects of sleep disordered breathing and metabolic syndrome on endothelial function: the Wisconsin Sleep Cohort study. Sleep. 2014;37:1707-13.

  31. Kaczmarek E, Bakker JP, Clarke DN, et al. Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One. 2013;8:e70559.

  32. Fleming WE, Ferouz-Colborn A, Samoszuk MK, Azad A, Lu J, Riley JS, et al. Blood biomarkers of endocrine, immune, inflammatory, and metabolic systems in obstructive sleep apnea. Clin Biochem. 2016;49:854-61.

  33. Kushida CA, Littner MR, Hirshkowitz M, et al.; American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006; 29:375-80.

  34. Batool-Anwar S, Goodwin JL, Kushida CA, et al. Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res. 2016. [Epub ahead of print].

  35. Martínez-Cerón E, Barquiel B, Bezos AM, et al. Effect of CPAP on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial. Am J Respir Crit Care Med. 2016;194:476-85.

  36. Guilleminault C, Kreutzer M, Chang JL. Pregnancy, sleep disordered breathing and treatment with nasal continuous positive airway pressure. Sleep Med. 2004;5:43-51.

  37. Poyares D, Guilleminault C, Hachul H, et al. Pre-eclampsia and nasal CPAP: part 2. Hypertension during pregnancy, chronic snoring, and early nasal CPAP intervention. Sleep Med. 2007;9:15-21.




2020     |     www.medigraphic.com